domains/health/AI scribes reached 92 percent provider adoption in under 3 years because documentation is the rare healthcare workflow where AI value is immediate unambiguous and low-risk.md

@@ -37,6 +37,12 @@ Abridge's clinical outcomes data shows 73% reduction in after-hours documentatio
 
 Epic launched AI Charting in February 2026, creating an immediate commoditization threat to standalone ambient AI platforms. Abridge's response - pivoting to 'more than a scribe' positioning with coding, prior auth automation, and clinical decision support - suggests leadership recognized the documentation beachhead may not be defensible against EHR-native solutions. The timing of this strategic pivot (2025-2026) indicates the scribe adoption success may have a shorter durability window than the 92% adoption figure suggests.
 
+
+### Additional Evidence (challenge)
+*Source: [[2026-01-01-bvp-state-of-health-ai-2026]] | Added: 2026-03-16*
+
+The 92% figure applies to 'deploying, implementing, or piloting' ambient AI as of March 2025, not active deployment. This includes very early-stage pilots. The scope distinction between pilot programs and daily clinical workflow integration is significant — the claim may overstate actual adoption if interpreted as active use rather than organizational commitment to explore the technology.
+
 ---
 
 Relevant Notes:

domains/health/AI-native health companies achieve 3-5x the revenue productivity of traditional health services because AI eliminates the linear scaling constraint between headcount and output.md

@@ -32,6 +32,12 @@ Since [[healthcares defensible layer is where atoms become bits because physical
 
 Abridge reached $100M ARR with 150+ health system customers by May 2025, achieving $5.3B valuation. This represents the clearest real-world validation of AI-native productivity claims in healthcare - a documentation platform scaling to 9-figure revenue without the linear headcount scaling that would be required for traditional medical transcription or documentation services.
 
+
+### Additional Evidence (confirm)
+*Source: [[2026-01-01-bvp-state-of-health-ai-2026]] | Added: 2026-03-16*
+
+BVP reports AI-native healthcare companies achieve $500K-$1M+ ARR per FTE with 70-80%+ software-like margins, compared to $100-200K for traditional healthcare services and $200-400K for pre-AI healthcare SaaS. This is the primary source for the productivity claim, providing the specific ranges that support the 3-5x multiplier.
+
 ---
 
 Relevant Notes:

domains/health/healthcare AI funding follows a winner-take-most pattern with category leaders absorbing capital at unprecedented velocity while 35 percent of deals are flat or down rounds.md

@@ -19,6 +19,12 @@ The emerging consensus: healthcare AI is a platform shift, not a bubble, but the
 
 **Bessemer corroboration (January 2026):** 527 VC deals in 2025 totaling an estimated $14B deployed. Average deal size increased 42% year-over-year (from $20.7M to $29.3M). Series D+ valuations jumped 63%. AI companies captured 55% of health tech funding (up from 37% in 2024). For every $1 invested in AI broadly, $0.22 goes to healthcare AI — exceeding healthcare's 18% GDP share. The Health Tech 2.0 IPO wave produced 6 companies with $36.6B combined market cap, averaging 67% annualized revenue growth. Health tech M&A hit 400 deals in 2025 (up from 350 in 2024), with strategic acquirers consolidating AI capabilities.
 
+
+### Additional Evidence (confirm)
+*Source: [[2026-01-01-bvp-state-of-health-ai-2026]] | Added: 2026-03-16*
+
+Abridge raised $300M Series E at $5B valuation and Ambiance raised $243M Series C at $1.04B valuation by early 2026, demonstrating the capital concentration in category leaders. Function Health's $300M Series C at $2.2B valuation further confirms winner-take-most dynamics in health AI.
+
 ---
 
 Relevant Notes:

inbox/archive/2026-01-01-bvp-state-of-health-ai-2026.md

@@ -7,9 +7,13 @@ date: 2026-01-01
 domain: health
 secondary_domains: []
 format: industry-report
-status: unprocessed
+status: enrichment
 priority: high
 tags: [health-ai, ai-native, revenue-productivity, ambient-scribes, clinical-ai, market-analysis, venture-capital]
+processed_by: vida
+processed_date: 2026-03-16
+enrichments_applied: ["AI-native health companies achieve 3-5x the revenue productivity of traditional health services because AI eliminates the linear scaling constraint between headcount and output.md", "AI scribes reached 92 percent provider adoption in under 3 years because documentation is the rare healthcare workflow where AI value is immediate unambiguous and low-risk.md", "healthcare AI funding follows a winner-take-most pattern with category leaders absorbing capital at unprecedented velocity while 35 percent of deals are flat or down rounds.md"]
+extraction_model: "anthropic/claude-sonnet-4.5"
 ---
 
 ## Content
@@ -63,3 +67,13 @@ Comprehensive annual landscape analysis of AI in healthcare from Bessemer Ventur
 PRIMARY CONNECTION: [[AI-native health companies achieve 3-5x the revenue productivity of traditional health services because AI eliminates the linear scaling constraint between headcount and output]]
 WHY ARCHIVED: Primary source for the existing KB productivity claim, plus the scope qualification issue on the 92% adoption figure
 EXTRACTION HINT: Note the scope qualification needed — 92% "deploying/implementing/piloting" vs. active deployment is a meaningful distinction. The extractor should flag this when reviewing the existing KB claim.
+
+
+## Key Facts
+- Traditional healthcare services: $100-200K ARR per FTE
+- Healthcare SaaS (pre-AI): $200-400K ARR per FTE
+- AI-native healthcare: $500K-$1M+ ARR per FTE
+- AI-native healthcare companies achieve 70-80%+ software-like margins
+- As of March 2025: 92% of provider health systems deploying, implementing, or piloting ambient AI
+- Early ambient AI adopters report 10-15% revenue capture improvements through better coding and documentation in year 1
+- Health tech companies hitting $100M+ ARR in under 5 years represents compression of time-to-scale